BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Li M, Zhang L, Xie S, Sun F, Zeng Z, Deng W, Jiang T, Bi X, Lin Y, Yang L, Lu Y, Shen G, Liu R, Wu S, Chang M, Hu L, Dong J, Yi W, Xie Y. Dynamic Changes of Cytokine Profiles and Virological Markers Associated With HBsAg Loss During Peginterferon Alpha-2a Treatment in HBeAg-Positive Chronic Hepatitis B Patients. Front Immunol 2022;13:892031. [PMID: 35603222 DOI: 10.3389/fimmu.2022.892031] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Wang WX, Jia R, Jin XY, Li X, Zhou SN, Zhang XN, Zhou CB, Wang FS, Fu J. Serum cytokine change profile associated with HBsAg loss during combination therapy with PEG-IFN-α in NAs-suppressed chronic hepatitis B patients. Front Immunol 2023;14:1121778. [PMID: 36756119 DOI: 10.3389/fimmu.2023.1121778] [Reference Citation Analysis]
2 Yang J, Lu H, Chen B, Jiang L, Zhang H, Ye P, Jin L. Profiling of Peripheral TRBV and CD4+CD25+ Treg in CHB Patients with HBeAg SC during TDF Treatment. J Immunol Res 2023;2023:1914036. [PMID: 36660247 DOI: 10.1155/2023/1914036] [Reference Citation Analysis]
3 Su YT, Chang ML, Liaw YF. Case report: Unusual viral evolutions following antiviral therapies in a patient with concurrent hepatitis B virus and hepatitis C virus infection. Front Med (Lausanne) 2023;10:1136111. [PMID: 36873880 DOI: 10.3389/fmed.2023.1136111] [Reference Citation Analysis]
4 Qi W, Wang Y, Huang G, Wang K. Interleukin‐2 promotes pegylated interferon alpha for hepatitis B surface antigen loss: A retrospective pragmatic clinical study at the Fourth Affiliated Hospital of Zhejiang University Medical College. Health Science Reports 2022;5. [DOI: 10.1002/hsr2.932] [Reference Citation Analysis]
5 Chen S, Liu X, Liu H, Lou J. The incidence rate, serological characteristics and cytokines profile of occult HBV infection in clinic.. [DOI: 10.21203/rs.3.rs-2171086/v1] [Reference Citation Analysis]
6 Li M, Gao Y, Yang L, Lin Y, Deng W, Jiang T, Bi X, Lu Y, Zhang L, Shen G, Liu R, Wu S, Chang M, Xu M, Hu L, Song R, Jiang Y, Yi W, Xie Y. Dynamic changes of cytokine profiles and virological markers during 48 weeks of entecavir treatment for HBeAg-positive chronic hepatitis B. Front Immunol 2022;13:1024333. [DOI: 10.3389/fimmu.2022.1024333] [Reference Citation Analysis]